Invention Grant
- Patent Title: Pharmaceutically active disubstituted triazine derivatives
- Patent Title (中): 药用活性二取代三嗪衍生物
-
Application No.: US14002730Application Date: 2012-03-01
-
Publication No.: US09226929B2Publication Date: 2016-01-05
- Inventor: Gerd Rühter , Uwe Koch , Peter Nussbaumer , Carsten Schulz-Fademrecht , Jan Eickhoff
- Applicant: Gerd Rühter , Uwe Koch , Peter Nussbaumer , Carsten Schulz-Fademrecht , Jan Eickhoff
- Applicant Address: DE Monheim
- Assignee: Bayer Intellectual Property GMBH
- Current Assignee: Bayer Intellectual Property GMBH
- Current Assignee Address: DE Monheim
- Priority: EP11075037 20110302
- International Application: PCT/EP2012/053504 WO 20120301
- International Announcement: WO2012/117048 WO 20120907
- Main IPC: C07D251/12
- IPC: C07D251/12 ; C07D401/04 ; C07D403/04 ; C07D513/04 ; A61K31/5377 ; A61K31/53 ; A61K31/5355 ; C07D251/48 ; C07D471/04 ; C07D487/04 ; C07D495/04 ; A61K45/06 ; C07D403/14 ; C07D413/04
Abstract:
The present invention relates to disubstituted triazine derivatives and/or pharmaceutically acceptable salts thereof, the use of these derivatives as pharmaceutically active agents, especially for the prophylaxis and/or treatment of infectious diseases, including opportunistic diseases, immunological diseases, autoimmune diseases, cardiovascular diseases, cell proliferative diseases, inflammation, erectile dysfunction and stroke, and pharmaceutical compositions containing at least one of said disubstituted triazine derivatives and/or pharmaceutically acceptable salts thereof. Furthermore, the present invention relates to the use of said disubstituted triazine derivatives as inhibitors for a protein kinase.
Public/Granted literature
- US20140179662A1 PHARMACEUTICALLY ACTIVE DISUBSTITUTED TRIAZINE DERIVATIVES Public/Granted day:2014-06-26
Information query
